# clm_16ACF812759A

subject: Preferred Networks (/record/preferred-networks.md)  
predicate: partnership  
value: Curreio  
valid_from: 2021-04-05  
valid_to: null  
published: 2021-04-04  
recorded: 2026-11-14  
confidence: 0.70  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-14  
cite: AsOf. "Preferred Networks partnership: Curreio", as of 2021-04-05. Claim clm_16ACF812759A, https://asof.is/claim/clm_16ACF812759A, accessed 2026-11-14. Source: https://www.preferred.jp/en/news/pr20210405.  
checked: 2026-11-14 · its source page states the value and the date, as read by an AI model  

> TOKYO – April 5, 2021 – Curreio, Inc. (Curreio) and Preferred Networks, Inc. (PFN) announced today that the companies have started collaborative research for discovery of novel drug candidates using their deep learning and structural analysis technologies.

What https://www.preferred.jp/en/news/pr20210405 says, word for word.

## Sources

- https://www.preferred.jp/en/news/pr20210405 (primary, Preferred Networks, published 2021-04-04)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.